Chairs: Robert Moritz, United States, Sue Weintraub, United States
Relevance and Future Projections of Proteomics in the Pharmaceutical Industry, Jennie Lil, United States
Translating Proteomics to the Clinical Arena, Michael Roehrl, United States
Target 2035 - Pharmacological Modulators for All Human Proteins, Cheryl Arrowsmith, Canada
Expanding Proteomics Beyond the Proteomic Community, Jochen Schwenk, Sweden
Bringing context to substance, Relevance of the Human Proteome Project, Robert Moritz, United States
Review and Updates (Future Planning/Developments)
- C-HPP, Chris Overall, United States
- B/D-HPP, Ileana Cristea, United States
- Initiatives and 4 Resource Pillars, Cecilia Lindskog, Sweden, Eric Deutsch, United States, Lydie Lane, Switzerland, Ed Nice, Australia, Michael Roehrl, United States and Susan Weintraub, United States
Written Questions from the Floor